Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography.

OBJECTIVES We compared three techniques to predict functional recovery after revascularization. BACKGROUND Recently, fluorine-18 (F-18) fluorodeoxyglucose in combination with single-photon emission computed tomography (SPECT) has been proposed to identify viable myocardium, Thallium-201 reinjection and low dose dobutamine echocardiography are used routinely for this purpose. METHODS Seventeen patients (mean [+/- SD] left ventricular ejection fraction 36 +/- 11%) were studied. Regional and global ventricular function were evaluated before and 3 months after revascularization by echocardiography and radionuclide ventriculography, respectively. Myocardial F-18 fluorodeoxyglucose uptake (during hyperinsulinemic glucose clamping) was compared with rest perfusion assessed with early thallium-201 SPECT. On a separate day, low dose dobutamine echocardiography and post-stress thallium-201 reinjection SPECT were simultaneously performed. RESULTS The sensitivities for F-18 fluorodeoxyglucose/thallium-201, thallium-201 reinjection and low dose dobutamine echocardiography to assess recovery were 89%, 93% and 85%, respectively; specificities were 77%, 43% and 63%, respectively. Stepwise logistic regression indicated that F-18 fluorodeoxyglucose/ thallium-201 was the best predictor. In hypokinetic segments, the combination of F-18 fluorodeoxyglucose/thallium-201 and low dose dobutamine echocardiography was the best predictor. Global function improved (left ventricular ejection fraction increased > 5%) in 6 patients and remained unchanged in 11. All three techniques correctly identified five of six patients with improvement. Fluorine-18 fluorodeoxyglucose/thallium-201 identified all patients without improvement; low dose dobutamine echocardiography identified 9 of 11 without improvement; and thallium-201 reinjection identified 6 of 11 patients without improvement. CONCLUSIONS Fluorine-18 fluorodeoxyglucose/thallium-201 SPECT was superior to the other techniques in assessing functional recovery. Integration of metabolic and functional data is necessary, particularly in hypokinesia, for optimal prediction of improvement of regional function.

[1]  M P Sandler,et al.  FDG-SPECT: correlation with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  D. Mason,et al.  Myocardial hibernation and "embalmment". , 1990, American heart journal.

[3]  U. Ruotsalainen,et al.  Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  W. Zoghbi,et al.  Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.

[5]  B E Oppenheim,et al.  Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  H R Schelbert,et al.  Metabolic imaging to assess myocardial viability. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  A. Bol,et al.  Mechanisms of Chronic Regional Postischemic Dysfunction in Humans New Insights From the Study of Noninfarcted Collateral‐Dependent Myocardium , 1993, Circulation.

[8]  O. Alfieri,et al.  Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.

[9]  J B Seward,et al.  Standardized nomenclature and anatomic basis for regional tomographic analysis of the heart. , 1981, Mayo Clinic proceedings.

[10]  F J Ten Cate,et al.  Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. , 1995, Circulation.

[11]  U. Ruotsalainen,et al.  The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Jeroen J. Bax,et al.  The Role of Fluorine-18-Deoxyglucose Single Photon Emission Computed Tomography in Predicting Reversibility of Regional Wall Motion Abnormalities after Revascularization , 1995 .

[13]  L. Becker,et al.  Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole, and coronary artery occlusion. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  S L Bacharach,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.

[16]  E. Hoffman,et al.  Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  F. Fazio,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. Schwaiger,et al.  Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. , 1994, Circulation.

[19]  Jeroen J. Bax,et al.  Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography. , 1993, European heart journal.

[20]  A. Soricelli,et al.  Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. , 1995, Circulation.

[21]  H. Schelbert,et al.  Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  W. J. Maclntyre,et al.  Metabolic Responses of Hibernating and Infarcted Myocardium to Revascularization: A Follow‐up Study of Regional Perfusion, Function, and Metabolism , 1992, Circulation.

[23]  Y. Yonekura,et al.  Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. , 1990, The American journal of cardiology.

[24]  R O Bonow,et al.  Current Diagnostic Techniques of Assessing Myocardial Viabilit in Patients With Hibernating and Stunned Myocardium , 1993, Circulation.

[25]  C. Visser,et al.  Prognostic implications of regional hyperkinesia and remote asynergy of noninfarcted myocardium. , 1986, The American journal of cardiology.

[26]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[27]  V. Dilsizian,et al.  Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. , 1992, Circulation.

[28]  V. Dilsizian,et al.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. , 1990, The New England journal of medicine.